Dynamics of Prion Proliferation Under CombinedTreatment of Pharmacological Chaperones andInterferons via a Mathematical Model
A. Ghosh, D. N. Garzon, Y. Castillo, M. Navas-Zuloaga, N. Culik, L. Darwin, A. Hardin, A. Yang, C. C. Garsow, K. Rios-Soto
Abstract
Prion diseases are lethal neurodegenerative disorders such as mad cow disease in bovines, chronic wasting disease in cervids, and Creutzfeldt-Jakob disease in humans. They are caused when the prion protein PrPC misfolds into PrPSc, which is capable of inducing further misfolding in healthy PrPC proteins. Recent in vivo experiments show that pharmacological chaperones can temporarily prevent this conversion by binding to PrPC molecules, and thus constitute a possible treatment. A second strategic approach uses interferons to decrease the concentration of PrPSc. In order to study the quantitative effects of these treatments on prion proliferation, we develop a model using a non-linear system of ordinary differential equations. By evaluating their efficacy and potency, we find that interferons act at lower doses and achieve greater prion decay rates. However, there are benefits in combining them with pharmacological chaperones in a two-fold therapy. This research is crucial to guide future prion experiments and inform potential treatment protocols.Competing Interest StatementThe authors have declared no competing interest.View Full Text
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anti-prion drugs do not improve survival in knock-in models of inherited prion disease
D. Walsh, J. Rees, … S. Supattapone·bioRxiv·Sep 28, 2023
- Therapeutic window for treatment of prion disease defined by timed depletion of Prion protein
Barry Matthew Bradford, Alison Marshall, … Jean C. Manson·bioRxiv·Nov 18, 2024
- PrP turnover in vivo and the time to effect of prion disease therapeutics
Taylor L Corridon, Jill O’Moore, … Eric Vallabh Minikel·PLoS PathogensPeer-reviewed·May 26, 2026
- Analysis of non-human primate models for evaluating prion disease therapeutic efficacy
Meredith A Mortberg, Eric Vallabh Minikel, Sonia M. Vallabh·PLoS PathogensPeer-reviewed·Aug 22, 2022
- The dynamics of prion spreading is governed by the interplay between the non-linearities of tissue response and replication kinetics
Basile Fornara, Angélique Igel‐Egalon, … Human Rézaei·iSciencePeer-reviewed·Nov 13, 2024
- Prevention of prion disease symptoms in mice with deep PrP lowering
Juliana E Gentile, Jonathan E. Farley, … Eric Vallabh Minikel·bioRxiv·Oct 24, 2026